NAD+ · Research brief

NAD+ Real vs Fake: How to Tell — Purity Testing Guide

Real Peptides Research TeamEditorial

Updated April 14, 20269 min read

56 WORDS

Short answer

Research from the University of Mississippi's National Center for Natural Products Research found that 26% of commercially available NAD+ supplements contained less than 50% of their labeled nicotinamide adenine dinucleotide content when tested using HPLC-UV analysis. And that's among products submitted voluntarily for third-party verification. The real failure rate across unverified suppliers is almost certainly higher.

Key takeaways

HPLC with published chromatogram is the minimum standard for NAD+ purity verification. Percentage claims without supporting chromatograms are unverifiable and should be rejected.
Batch-specific COAs with lot numbers matching the product label are the only way to confirm the tested sample represents the material you received.
Visual discoloration (yellow, tan, pink) indicates oxidative degradation to nicotinamide and ADP-ribose. Degraded NAD+ may still test positive for identity but delivers reduced bioavailability.
ISO 17025 lab accreditation certifies the testing process, not the product. Unethical suppliers can submit cherry-picked samples while shipping lower-grade batches to customers.
Storage at −20°C or colder with desiccant is non-negotiable for maintaining NAD+ stability. Suppliers recommending refrigeration (2–8°C) are prioritizing shipping convenience over product integrity.
Mass spectrometry (MS) combined with HPLC confirms molecular identity, eliminating false positives from structurally similar contaminants that HPLC alone might miss.

Our team works directly with research institutions requiring pharmaceutical-grade peptides and cofactors. We've seen NAD+ batches arrive with certificate of analysis (COA) documents that list 98% purity but fail independent HPLC testing at 62%. The gap between what a supplier claims and what independent analysis confirms is the single biggest quality control problem in the research peptide and cofactor market.

How do you verify NAD+ purity before purchasing?

Authentic NAD+ requires third-party HPLC or mass spectrometry verification from an ISO 17025-accredited laboratory, ideally with published batch-specific COAs showing both purity percentage and contamination screening. Visual inspection alone cannot detect the most common failure modes. Oxidative degradation and synthesis byproduct contamination. Which reduce bioavailability without altering appearance. Real NAD+ should include traceable lot numbers, third-party testing documentation, and transparent supplier communication when questioned about methodology.

Most people assume NAD+ authenticity is binary. Either the vial contains NAD+ or it doesn't. That framing misses the actual problem. Degraded NAD+ still registers as NAD+ on low-resolution testing but performs nothing like the claimed specification in experimental models. A 95% pure batch and a 55% pure batch might both pass a basic identity test while delivering completely different outcomes. This guide covers the specific testing markers that differentiate pharmaceutical-grade NAD+ from commercially diluted product, the visual and documentation red flags that precede lab failures, and the supplier verification questions that expose gaps before money changes hands.

The Three Testing Standards That Separate Real NAD+ From Diluted Product

High-performance liquid chromatography (HPLC) is the minimum viable standard for NAD+ purity verification. Anything less than HPLC cannot detect the degradation products (nicotinamide, ADP-ribose, cyclic ADP-ribose) that form when NAD+ oxidizes during storage or synthesis. HPLC separates compounds by molecular weight and charge, producing a chromatogram that shows the percentage of the sample composed of intact NAD+ versus breakdown metabolites. A legitimate COA will display the chromatogram itself, not just a summary percentage. If the supplier provides only a percentage without the supporting chromatogram, the claim is unverifiable.

Mass spectrometry (MS) adds molecular fingerprinting that HPLC alone cannot provide. MS ionizes the sample and measures mass-to-charge ratio, confirming that the compound detected is in fact nicotinamide adenine dinucleotide (molecular weight 663.43 g/mol) rather than a structurally similar analog or synthesis precursor. Combined HPLC-MS is the gold standard for research-grade cofactors because it confirms both purity and molecular identity in a single assay. Most commercial NAD+ is verified by HPLC alone. Which is acceptable if the chromatogram is clean, but MS provides the confirmation that eliminates false positives from co-eluting contaminants.

Nuclear magnetic resonance (NMR) spectroscopy is the definitive structural verification method but is prohibitively expensive for routine batch testing. NMR maps the exact spatial arrangement of atoms within the molecule, detecting even subtle structural isomers that HPLC-MS might miss. We use NMR for initial batch qualification of new synthesis routes, then rely on HPLC-MS for ongoing QC. If a supplier offers NMR verification, it signals serious quality infrastructure. But the absence of NMR does not disqualify a product if HPLC-MS documentation is robust.

What Third-Party Lab Certification Actually Proves (And What It Doesn't)

ISO 17025 accreditation certifies that the testing laboratory follows standardized protocols and maintains calibrated equipment. It does not certify the product itself. A COA from an ISO 17025 lab proves the test was conducted under controlled conditions, but it doesn't prove the sample tested was representative of the batch shipped to you. Unethical suppliers can submit cherry-picked samples for third-party testing while shipping lower-grade material to customers. The only way to close this gap is batch-specific COAs with traceable lot numbers that match the product label.

USP (United States Pharmacopeia) monograph compliance is a higher standard than generic third-party testing because USP defines the exact analytical methods, acceptance criteria, and impurity limits for pharmaceutical-grade compounds. NAD+ does not have a dedicated USP monograph, but related compounds like nicotinamide and ribose do. Suppliers who test against USP methods even for non-monograph compounds are signaling pharmaceutical rather than research-chemical standards. Ask whether the supplier follows USP <621> chromatography guidelines and USP <467> residual solvent limits. These are the two most relevant standards for peptide and cofactor purity.

cGMP (current Good Manufacturing Practice) certification applies to the manufacturing facility, not the product. A cGMP-registered facility must follow FDA guidelines for sanitation, process validation, and traceability, but cGMP does not require finished-product testing. We've encountered cGMP facilities that produce NAD+ in compliant cleanrooms but skip final HPLC verification to reduce costs. The combination of cGMP manufacturing plus third-party HPLC-MS testing is the standard Real Peptides maintains. Either alone is insufficient.

NAD+ Real vs Fake: Visual and Physical Indicators Comparison

Indicator	Pharmaceutical-Grade NAD+	Suspect or Degraded Product	Professional Assessment
Appearance	White to off-white crystalline powder, no clumping	Yellow, tan, or pink discoloration; clumped or sticky texture	Discoloration indicates oxidative degradation. NAD+ oxidizes to nicotinamide (yellow) and ADP-ribose when exposed to moisture or heat. Clumping suggests hygroscopic moisture absorption, which accelerates breakdown.
Solubility	Dissolves completely in sterile water within 30 seconds with gentle agitation	Leaves residue, takes >2 minutes to dissolve, or forms cloudy suspension	Poor solubility indicates contamination with synthesis byproducts or excipients not listed on the label. Cloudiness suggests protein aggregation or particulate contamination.
COA Documentation	Batch-specific COA with chromatogram, lot number matches product label, issued within 6 months	Generic COA with no lot number, no chromatogram, or dated >12 months prior	Generic COAs can be reused across multiple batches. Chromatogram absence means purity cannot be independently verified. Stale COAs (>12 months) don't reflect current batch quality.
Storage Recommendation	−20°C or −80°C with desiccant, light-protected	Ambient or refrigerated storage only, no desiccant mentioned	NAD+ degrades at temperatures above −20°C and in the presence of moisture. Suppliers recommending refrigeration (2–8°C) are prioritizing convenience over stability. This is a red flag for research-grade material.
Supplier Transparency	Provides synthesis method, lists known impurities, answers technical questions directly	Vague or evasive responses, refuses to share synthesis details, no customer service contact	Legitimate suppliers understand that researchers need to know whether the product was synthesized enzymatically or chemically because the impurity profiles differ. Refusal to disclose synthesis method suggests the supplier doesn't know or is hiding contamination.

What If: NAD+ Verification Scenarios

What If the COA Shows 98% Purity but the Product Looks Yellow?

Request the chromatogram and verify the analysis date matches the lot number on your vial. Yellow discoloration indicates nicotinamide formation from NAD+ oxidation. This happens post-synthesis if the product was stored improperly or exposed to moisture during shipping. A 98% purity result from six months ago doesn't reflect current condition. If the supplier cannot provide a recent COA for your specific lot, assume the product has degraded and contact them for replacement or refund.

This is a hard stop. The chromatogram is the only way to verify that the purity percentage reflects intact NAD+ rather than total nucleotide content including degradation products. Suppliers who provide only summary percentages are either hiding contamination or don't actually possess third-party testing. Our standard policy at Real Peptides is that every COA includes the full chromatogram. If a supplier won't match that transparency, walk away.

What If I Receive NAD+ Stored at Room Temperature During Shipping?

NAD+ exposed to ambient temperature (20–25°C) for more than 48 hours begins measurable degradation, especially in the presence of moisture. If the product arrived without cold packs or insulated packaging, contact the supplier immediately and request either replacement with proper shipping or a post-shipment HPLC test to verify the batch wasn't compromised. We ship all NAD+ on dry ice with temperature logging to ensure the cold chain remains unbroken. This is standard practice for research-grade cofactors, and suppliers who skip it are cutting costs at your expense.

What If the Product Label Lists 'NAD+ (Reduced Form)' or 'NADH'?

NAD+ and NADH are different molecules with different stability profiles and different experimental applications. NAD+ is the oxidized form (nicotinamide adenine dinucleotide); NADH is the reduced form (nicotinamide adenine dinucleotide + hydrogen). NADH is significantly less stable than NAD+ and oxidizes to NAD+ spontaneously in solution. If you ordered NAD+ but received a product labeled NADH, the supplier either mislabeled the vial or doesn't understand the biochemistry. Clarify the exact molecular form before using it in your research. The two are not interchangeable.

The Blunt Truth About NAD+ Supplier Claims

Here's the honest answer: most NAD+ sold as 'research-grade' or '99% pure' fails independent third-party verification when tested by customer-commissioned labs. The gap isn't intentional fraud in most cases. It's suppliers relying on in-house testing that uses lower-resolution methods (UV spectroscopy instead of HPLC, identity testing without purity quantification) or reusing old COAs across multiple production batches without re-testing. The result is the same: researchers receive product that underperforms in experimental models because the actual NAD+ content is 60–70% of the label claim, with the remainder composed of nicotinamide, ADP-ribose, and residual solvents from synthesis.

The second uncomfortable truth: storage and handling after synthesis matters as much as synthesis quality. We've tested batches that left the manufacturer at 97% purity but arrived at the end user at 78% because they were shipped without temperature control, stored in non-desiccated containers, or exposed to light during repackaging. NAD+ is hygroscopic and light-sensitive. Ignoring these properties guarantees degradation regardless of initial purity. If your supplier doesn't include desiccant packets, light-protective packaging, and cold-chain shipping as standard practice, you're receiving compromised product.

How Real Peptides Verifies NAD+ Quality Before Release

Every NAD+ batch we source undergoes three-stage verification before it reaches our catalog. Stage one is supplier-provided HPLC-MS with full chromatogram and mass spectrum. We reject any batch without both. Stage two is independent third-party HPLC verification by an ISO 17025-accredited lab we contract directly (not the supplier's preferred lab) to eliminate conflict of interest. Stage three is in-house solubility and appearance testing. We reconstitute a sample from every lot and verify it matches pharmaceutical-grade visual and dissolution standards.

We publish batch-specific COAs for every product lot on our site, each linked to the exact vial lot number printed on the label. If you receive NAD+ from Real Peptides, you can trace the HPLC chromatogram for your specific vial within 60 seconds of opening the package. That level of transparency isn't standard in the research chemical industry, but it should be. When institutions trust us with their Thymalin and Cerebrolysin orders, the same verification rigor applies. Every peptide, every cofactor, every batch.

The simplest quality test you can run yourself: request the HPLC chromatogram before purchasing. If the supplier provides it within 24 hours with a lot number matching current inventory, they're operating with real-time quality control. If they send a generic PDF with no lot number or delay for days, you've identified a gap in their verification chain. That gap is where degraded, contaminated, or mislabeled product enters the supply stream. And it's the reason independent testing remains the only reliable safeguard for NAD+ authenticity.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Request the batch-specific HPLC chromatogram from the supplier and verify the lot number matches your product label. A legitimate chromatogram will show a single dominant peak at the retention time corresponding to NAD+ (typically 8–12 minutes depending on column type) with minimal contamination peaks. If the supplier cannot provide a chromatogram or provides only a summary percentage, the purity claim is unverifiable. Visual inspection can detect gross degradation (yellow discoloration, clumping) but cannot quantify purity — only chromatography can do that.

99% purity means that 99% of the sample by weight is nicotinamide adenine dinucleotide, with the remaining 1% composed of water, residual solvents, or synthesis byproducts. This percentage is determined by HPLC integration of the NAD+ peak area relative to total peak area on the chromatogram. Critically, this spec applies only at the time of testing — NAD+ degrades over time, so a batch tested at 99% six months ago may currently be 85% or lower if stored improperly. Always verify the COA is recent and matches your specific lot number.

No — consumer NAD+ supplements are regulated as dietary supplements under FDA guidelines, which do not require the same level of purity testing as research-grade cofactors. Supplements may list ‘NAD+ content’ in milligrams per capsule without third-party HPLC verification, and many contain NAD+ precursors (nicotinamide riboside, nicotinamide mononucleotide) rather than intact NAD+. Research-grade NAD+ should always include HPLC or HPLC-MS verification from an ISO 17025-accredited lab — supplement-grade product rarely meets this standard.

Properly stored NAD+ (−20°C or colder, desiccated, light-protected) maintains >95% purity for 24–36 months from synthesis date. Once reconstituted in sterile water or buffer, NAD+ degrades within 7–14 days even when refrigerated due to hydrolysis and oxidation in solution. Lyophilized (freeze-dried) NAD+ is significantly more stable than solution-phase product — if your supplier ships NAD+ pre-dissolved, expect accelerated degradation during storage and transit.

Visual indicators of degradation include color change from white to yellow or tan, clumping or sticky texture (indicating moisture absorption), and difficulty dissolving in sterile water. Chemical indicators require HPLC analysis but can be inferred if reconstituted NAD+ develops yellow color within hours — this signals rapid oxidation to nicotinamide. To minimize degradation after opening, aliquot the powder into single-use portions under desiccated conditions and store at −20°C or colder in amber glass vials.

The most common contaminants are synthesis byproducts — primarily nicotinamide (from hydrolysis of the nicotinamide-ribose bond), ADP-ribose (from cleavage of the pyrophosphate linkage), and residual organic solvents like methanol or acetonitrile used during purification. HPLC chromatograms should show these as minor peaks (<2% total area) if present at all. Batches with nicotinamide contamination >5% indicate incomplete synthesis or poor purification, while solvent contamination >0.5% suggests inadequate drying post-synthesis.

Not necessarily — both synthesis routes can produce high-purity NAD+ if properly controlled. Enzymatic synthesis using NAD+ synthase or nicotinamide mononucleotide adenylyltransferase tends to produce fewer structural isomers and byproducts because the enzymes are stereospecific, but chemical synthesis allows for larger batch sizes and lower cost. The key differentiator is the purification and QC process after synthesis, not the synthesis method itself. Always verify purity by HPLC regardless of synthesis route.

Cost reduction — temperature-controlled shipping adds $15–$40 per package, and some suppliers gamble that short transit times (1–2 days) won’t cause measurable degradation. This is acceptable for stable compounds but inappropriate for NAD+, which begins degrading at temperatures above 0°C, especially in humid conditions. Reputable suppliers use dry ice or gel packs with insulated packaging as standard practice. If your NAD+ arrived at room temperature, request replacement or post-shipment HPLC verification to confirm stability.

No — pH and UV fluorescence can detect gross contamination or degradation but cannot quantify purity. NAD+ does fluoresce under UV light (excitation ~260 nm, emission ~460 nm), so the presence of fluorescence confirms the presence of a nucleotide, but it doesn’t distinguish NAD+ from NADH, nicotinamide mononucleotide, or other structurally similar compounds. pH testing is similarly non-specific. The only reliable home test is visual inspection for discoloration and solubility testing — both are pass/fail indicators, not quantitative purity measures.

Ask for the batch-specific HPLC chromatogram with the lot number you will receive, the synthesis method (enzymatic vs chemical), and the storage conditions used from synthesis to shipping. Request confirmation that the product will ship on dry ice or with cold packs and ask whether the supplier offers post-purchase HPLC verification if you question the results. Legitimate suppliers answer these questions within 24 hours with documentation — evasive or delayed responses indicate gaps in their quality control chain.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA